# Drug Interaction Study to Investigate Co-administration of GW642444M With Ketoconazole

> **NCT00866515** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 20 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** Ketoconazole + GW642444M
- **DRUG:** Placebo + GW642444M

## Key facts

- **NCT ID:** NCT00866515
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12-22
- **Primary completion:** 2009-03-27
- **Final completion:** 2009-03-27
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00866515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00866515, "Drug Interaction Study to Investigate Co-administration of GW642444M With Ketoconazole". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00866515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*